Calithera Biosciences (NASDAQ:CALA) Coverage Initiated at StockNews.com

Analysts at StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a report released on Saturday. The firm set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Shares of CALA opened at $0.01 on Friday. The company’s 50 day simple moving average is $0.01 and its 200 day simple moving average is $0.01. Calithera Biosciences has a 1 year low of $0.00 and a 1 year high of $0.12.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.